November 11, 2025

European ports and fuel providers are locking in the clean transition

European ports and fuel suppliers are locking in clean transport corridors now, reshaping the future of low-carbon maritime trade...

Cerillion event highlights collaboration and next‑phase product push

Cerillion’s recent customer forum reveals its evolving role from software vendor to collaborative ecosystem partner for telecoms transformation...

ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video)

ICG Enterprise Trust posted strong 15% EBITDA growth with improving margins and realisation proceeds already ahead of last year. Hardman & Co’s Mark Thomas breaks down the trust’s recent performance..

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...

When HCP Dialogue Becomes Quantifiable Intelligence

Talking Medicines’ DrugVoice platform turns real‑world HCP dialogue into measurable insight, letting brand‑teams forecast message resonance before launch...

Time Finance offers a single‑solution approach to complex SME financing needs

For SMEs managing growth or transition, the financing challenge often lies in aligning structure with fluctuating asset exposures. The business in question provides what it terms a “multi‑product solution” or..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 32.11% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG) commands attention in the healthcare sector with its distinctive focus on home health, hospice services, and senior living facilities. Headquartered in Eagle, Idaho, and..

Mineralys Therapeutics (MLYS) Stock Analysis: Uncovering Growth Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (MLYS) is drawing significant attention in the biotechnology space as it continues to make strides in the development of innovative treatments for cardiorenal conditions. With a market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a compelling opportunity within the Healthcare sector, particularly in the Medical Care Facilities industry. With a market capitalization of $1.24 billion, HCSG..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 20.96% Potential Upside in the Thriving Cell and Gene Therapy Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.27 billion, BioLife Solutions is..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 23.97% Potential Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, specializes in developing and marketing non-opioid pain management and regenerative health solutions. With a market capitalization of approximately..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential amid Positive Analyst Consensus

NeoGenomics, Inc. (NEO) stands out in the healthcare sector with its specialized focus on diagnostics and research, particularly in cancer-focused testing laboratories. As the company navigates the complexities of the..

Innoviva, Inc. (INVA) Stock Analysis: A Bold 74% Upside Potential for Biotech Investors

Innoviva, Inc. (NASDAQ: INVA) stands out in the biotechnology sector with a remarkable potential upside of 74.41%, according to analyst ratings. With a market capitalization of $1.56 billion, Innoviva engages..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 99.69% Upside in the Rapidly Growing Eyecare Sector

Harrow, Inc. (HROW) is making waves in the healthcare sector, specifically within the niche of ophthalmic pharmaceuticals. Founded in 1998 and headquartered in Nashville, Tennessee, the company has recently transformed..

Travere Therapeutics (TVTX) Stock Analysis: A 20% Upside Potential in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX), a notable player in the biotechnology sector, has caught the attention of investors with its promising growth trajectory and substantial upside potential. The company, specializing..

Biohaven Ltd. (BHVN) Stock Analysis: A 440% Upside Potential in the Biotech Sector

For investors with an appetite for high-risk, high-reward opportunities, Biohaven Ltd. (NASDAQ: BHVN) presents an intriguing proposition. This biotech company, headquartered in New Haven, Connecticut, has carved a niche in..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 28.59% Potential Upside in Healthcare Innovation

Omnicell, Inc. (NASDAQ: OMCL) stands as a compelling player within the healthcare sector, particularly in the health information services industry. With a market capitalization of $1.65 billion, Omnicell is not..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Impressive Revenue Growth and a Promising 23.55% Upside

ANI Pharmaceuticals, Inc. (NYSE: ANIP) is gaining attention in the healthcare sector with its robust performance metrics and promising analyst ratings, making it a compelling choice for investors seeking growth..

Dynavax Technologies Corp (DVAX) Investor Outlook: Exploring a 106.52% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.3 billion, this Emeryville, California-based..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 40.49% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the healthcare sector, capturing investor attention with a compelling potential upside of 40.49%. With a market capitalization of $1.81 billion, this..

Search

Funds

November 11, 2025

European ports and fuel providers are locking in the clean transition

European ports and fuel suppliers are locking in clean transport corridors now, reshaping the future of low-carbon maritime trade...

Cerillion event highlights collaboration and next‑phase product push

Cerillion’s recent customer forum reveals its evolving role from software vendor to collaborative ecosystem partner for telecoms transformation...

ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video)

ICG Enterprise Trust posted strong 15% EBITDA growth with improving margins and realisation proceeds already ahead of last year. Hardman & Co’s Mark Thomas breaks down the trust’s recent performance and outlook...

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...

When HCP Dialogue Becomes Quantifiable Intelligence

Talking Medicines’ DrugVoice platform turns real‑world HCP dialogue into measurable insight, letting brand‑teams forecast message resonance before launch...
Search

Funds

November 11, 2025

FTSE 100

Funds